-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
David J. Schlanger Sells 41,667 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
David J. Schlanger Sells 41,667 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Chairman David J. Schlanger sold 41,667 shares of the firm's stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $41.65, for a total transaction of $1,735,430.55. Following the sale, the chairman now owns 82,548 shares of the company's stock, valued at $3,438,124.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Progyny Stock Performance
Shares of NASDAQ:PGNY opened at $44.32 on Friday. The company has a market cap of $4.08 billion, a PE ratio of 96.35, a price-to-earnings-growth ratio of 11.08 and a beta of 1.85. Progyny, Inc. has a 52 week low of $25.67 and a 52 week high of $68.32. The firm has a 50 day simple moving average of $31.18 and a 200 day simple moving average of $37.49.
Get Progyny alerts:Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.05 by $0.04. The business had revenue of $195.00 million during the quarter, compared to the consensus estimate of $190.51 million. Progyny had a net margin of 7.39% and a return on equity of 17.11%. The firm's quarterly revenue was up 51.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.19 EPS. On average, equities analysts predict that Progyny, Inc. will post 0.18 earnings per share for the current year.
Institutional Investors Weigh In On Progyny
Hedge funds have recently made changes to their positions in the company. American Century Companies Inc. lifted its position in Progyny by 407.4% in the 4th quarter. American Century Companies Inc. now owns 2,323,001 shares of the company's stock worth $116,963,000 after buying an additional 1,865,151 shares in the last quarter. Baillie Gifford & Co. lifted its position in Progyny by 337,578.8% in the 1st quarter. Baillie Gifford & Co. now owns 1,337,208 shares of the company's stock worth $68,732,000 after buying an additional 1,336,812 shares in the last quarter. Riverbridge Partners LLC lifted its position in Progyny by 87.7% in the 1st quarter. Riverbridge Partners LLC now owns 1,525,055 shares of the company's stock worth $78,388,000 after buying an additional 712,722 shares in the last quarter. Wafra Inc. lifted its position in Progyny by 64.1% in the 1st quarter. Wafra Inc. now owns 1,252,197 shares of the company's stock worth $64,363,000 after buying an additional 489,179 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its position in Progyny by 13.3% in the 2nd quarter. Clearbridge Investments LLC now owns 3,652,887 shares of the company's stock worth $106,116,000 after buying an additional 429,385 shares in the last quarter. Hedge funds and other institutional investors own 82.51% of the company's stock.Progyny Company Profile
(Get Rating)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Read More
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
- Find and Profitably Trade Stocks at 52-Week Lows
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Chairman David J. Schlanger sold 41,667 shares of the firm's stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $41.65, for a total transaction of $1,735,430.55. Following the sale, the chairman now owns 82,548 shares of the company's stock, valued at $3,438,124.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
納斯達克(股票代碼：PGNY-GET Rating)董事長施蘭格在8月9日星期二的交易中出售了41,667股該公司股票。該股的平均售價為41.65美元，總成交金額為1,735,430.55美元。出售後，董事長現在擁有82,548股公司股票，價值3,438,124.20美元。這筆交易是在提交給美國證券交易委員會(Securities&Exchange Commission)的一份文件中披露的，可以通過這個鏈接訪問。
Progyny Stock Performance
Progyny股票表現
Shares of NASDAQ:PGNY opened at $44.32 on Friday. The company has a market cap of $4.08 billion, a PE ratio of 96.35, a price-to-earnings-growth ratio of 11.08 and a beta of 1.85. Progyny, Inc. has a 52 week low of $25.67 and a 52 week high of $68.32. The firm has a 50 day simple moving average of $31.18 and a 200 day simple moving average of $37.49.
納斯達克：PGNY上週五開盤報44.32美元。該公司市值為40.8億美元，市盈率為96.35倍，市盈率為11.08倍，貝塔係數為1.85。Progyny，Inc.的52周低點為25.67美元，52周高點為68.32美元。該公司的50日簡單移動均線切入位為31.18美元，200日簡單移動均線切入位為37.49美元。
Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.05 by $0.04. The business had revenue of $195.00 million during the quarter, compared to the consensus estimate of $190.51 million. Progyny had a net margin of 7.39% and a return on equity of 17.11%. The firm's quarterly revenue was up 51.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.19 EPS. On average, equities analysts predict that Progyny, Inc. will post 0.18 earnings per share for the current year.
納斯達克上一次發佈季度收益報告是在8月4日星期四。該公司公佈本季度每股收益為0.09美元，比普遍預期的0.05美元高出0.04美元。該業務本季度的收入為1.95億美元，而普遍預期為1.905億美元。Progyny的淨利潤率為7.39%，股本回報率為17.11%。該公司季度營收同比增長51.5%。去年同期，該公司每股收益為0.19美元。股票分析師平均預測，Progyny，Inc.本年度每股收益將為0.18美元。
Institutional Investors Weigh In On Progyny
機構投資者對Progyny的看法
Progyny Company Profile
Progyny公司簡介
(Get Rating)
(獲取評級)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Progyny，Inc.是一家福利管理公司，專門為美國僱主提供生育和家庭建設福利解決方案。其生育福利解決方案包括差異化福利計劃設計、個性化禮賓式會員支持服務和有選擇的生育專家網絡。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
- Find and Profitably Trade Stocks at 52-Week Lows
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 免費獲取StockNews.com關於Progyny的研究報告(PGNY)
- 霍尼韋爾看好穩定和多元化的股票
- 為什麼要投資高收益股利股票？
- 找到並獲利於52周低點的股票交易
- 迪士尼(NYSE：DIS)的股票剛剛給了投資者一個巨大的信號
- 清潔能源法案通過後，太陽能股大放異彩
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
接受Progyny Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Progyny和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧